Month: August 2024

In the medical device industry, precision and clarity in communication are crucial due to the high stakes involved in terms of patient safety and regulatory compliance. Misunderstandings can lead to errors that may have serious ramifications, highlighting the importance of a thorough understanding of industry-specific terminology and acronyms. To assist professionals in navigating the complex […]

Continue Reading

The Food and Drug Administration (FDA) has been defending Jeff Shuren, the former director of the agency’s medical device center, following a report by The New York Times. The report discussed potential conflicts of interest arising from Shuren’s professional role at the FDA and his wife Allison Shuren’s position as a legal counsel for medical […]

Continue Reading

Sepsis, a condition often more dangerous than heart attacks and strokes combined, is among the most deadly, costly, and complex challenges hospitals face today. Ajay Shah, the CEO of Cytovale, a medical diagnostics company based in San Francisco, emphasized the severity of sepsis and the critical need for rapid identification and treatment. In light of […]

Continue Reading

Procept Biorobotics has recently received 510(k) clearance from the FDA for Hydros, their updated surgical robot designed for prostate procedures. This marks a considerable advancement from their first-generation device, the Aquabeam, which received de novo authorization in 2017 and has been utilized in roughly 400 hospitals, performing 50,000 procedures to date. The original Aquabeam robot […]

Continue Reading

The Food and Drug Administration (FDA) is in the process of establishing an active postmarket surveillance system to enhance the safety monitoring of medical devices. This initiative follows a federal mandate from 2012 that requires improved tracking and oversight of medical devices after they are introduced to the market. The move aims to utilize real-world […]

Continue Reading

Regeneron Pharmaceuticals, a player in the pharmaceutical industry, faces a delay in joining the market of new multiple myeloma treatments due to a recent FDA rejection. The refusal to approve Regeneron’s drug candidate, linvoseltamab, was not based on issues with the drug itself but rather concerns regarding the third-party manufacturer responsible for its production. This […]

Continue Reading

Salcit Technologies, an India-based respiratory healthcare company, has recently partnered with the Google Research team to leverage Google’s Health Acoustic Representations (HeAR) technology in expanding the capabilities of their own bioacoustic AI technology, Swaasa. Swaasa utilizes HeAR to enhance research and improve the early detection of tuberculosis through analyzing cough sounds. This collaboration highlights the […]

Continue Reading

Edwards Lifesciences has recently acquired the transcatheter aortic valve replacement (TAVR) system from Genesis Medtech, specifically targeting severe aortic regurgitation treatment through their J-Valve system. This acquisition includes the purchase of the JC Medical business segment from Genesis, encompassing the intellectual property and commercial rights associated with the J-Valve system. Although the exact sale price […]

Continue Reading

The Food and Drug Administration (FDA) has recently granted market authorization to NowDiagnostics for its at-home syphilis blood test, marking a significant development in the realm of medical diagnostics. Known as the First To Know Syphilis Test, this is the first over-the-counter diagnostic tool of its kind, capable of delivering results in just 15 minutes […]

Continue Reading

Medtronic, a leading medical technology company, has demonstrated positive financial results in the first quarter of fiscal year 2025, highlighted by a revenue growth of 2.8% year-over-year, reaching $7.92 billion. This growth is driven by strong performances in various business segments, notably in the cardiovascular and diabetes sectors. The cardiovascular division itself grew by 5.5%, […]

Continue Reading